We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Valneva Announces Signing of an Exclusive License Agreement

News   Mar 18, 2015

 
Valneva Announces Signing of an Exclusive License Agreement
 
 
 

RELATED ARTICLES

Cancer-killing Virus Gives Immunotherapy a Helping Hand Tackling Hard-to-treat Cancer

News

Combining a cancer-killing virus with immunotherapy could effectively treat advanced cancers that affect the limbs, a new study reveals.

READ MORE

Cargo Trafficked Across Bacteria on "Treadmills"

News

Bacteria have more in common with human cells than first thought; cargo is transited along treadmill-like structures by viruses in a process similar to what is found in our own cells. Understanding the process is fundamental to developing tailor-made phages for resistant infections.

READ MORE

Checkmate for Hepatitis B in the Liver

News

Chronic infection with the hepatitis B virus has been conquered in a mouse model, thanks to the work of German researchers and T cell therapy.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE